The hypoxia-inducible factor 1 (HIF-1) signalling pathway has been proposed to be involved in resistance to RT; its radio-induced expression is responsible for the activation of SDF-1 and its cognate receptor CXCR4 [100], leading to monocyte recruitment as well as angiogenesis and tumor recurrence [101]. Here, HIF1A is linked to neoplasm.